Post-
Conditions
Interventions
Serum magnesium will be measured every follow-
up visit in all kidney transplant recipients in our institute. We will categorize patients into two groups according to serum magnesium levels as a time-
varying variable,
hypomagnesemia (serum magnesium level <1.48 mEq/L) and normal serum magnesium group (serum magnesium level ≥1.48 mEq/L). Relationship between serum magnesium levels and time to development of post&#
transplant diabetes or impaired fasting plasma glucose will be explore using joint model and controlling for other confounding factors.
Diagnostic
Kidney transplant recipients
Sponsors
Division of Nephrology, Department of Internal Medicine, Faculty of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Kidney transplant recipients at Chiang Mai University Hospital between January 2014 and May 2019. 2. Age of 18 years or older
Exclusion criteria
Exclusion criteria: 1. Diagnosis of impaired fasting plasma glucose or diabetes mellitus before kidney transplantation according to American Diabetic Association guideline 2. Patients who was diagnosed Post-transplant diabetes or impaired fasting plasma glucose within the 1st month after transplantation 3. Graft lost within the first 6 months after transplantation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to development of post-transplant diabetes mellitus Patients were followed until development of diabetes or until the last visit Diabetes mellitus was diagnosed according to American Diabetic Association Criteria | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to development of impaired fasting plasma glucose Patients were followed until development of impaired fasting plasma glucose or until the last visit Impaired fasting plasma glucose was diagnosed according to American Diabetic Association Criteria | — |
Countries
Thailand
Contacts
Public ContactKajohnsak Noppakun
Chiang Mai University
Outcome results
None listed